Skip to content

Australian reproductive biotechnology company Memphasys enhances board with appointment of Michael Atkins as Non-Executive Director

By API User

Australian-based reproductive biotechnology company, Memphasys Limited (ASX: MEM), has enhanced its board with the appointment of successful corporate executive Michael Atkins as an independent non-executive director, effective immediately. Since 1987 Michael has been involved with the formation of, and capital raising for, and management of, many listed companies on the ASX, both as a Chairman/Director … Continued

Moolec Science Presents Second Quarter Fiscal Year 2024 Business Update

By API User

LUXEMBOURG / ACCESSWIRE / March 13, 2024 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the second quarter of Fiscal Year 2024 ended December 31, 2023. Moolec Logo Moolec Science Logo The main highlights of Moolec’s … Continued

$3 million in Funding to Support Early-Stage Biomedtech Projects Focused on Minimising Antimicrobial Resistance Thanks to the CSIRO

By API User

Australia’s leading national biotech incubator, CUREator by Brandon BioCatalyst, today announced the allocation of $3 million to propel five promising Life Sciences projects in its third round.    These projects are part of the Minimising Antimicrobial Resistance (AMR) stream and target the growing threat of AMR. AMR occurs when disease-causing microbes can resist the effects … Continued

Blue Ocean Ventures Launches SHRMP.bio – a Blue Bio-Technology Startup Developing Sustainable Seafood Manufacturing Technologies.

By API User

The future of seafood is on land – and SHRMP.bio plans to create it.     [Melbourne, Victoria, Australia]: Venture studio Blue Ocean Ventures today announced the spinning out of its first development project. The new biotech startup SHRMP.bio is developing the technologies to build a seafood manufacturing system ready for the challenges of the 21st Century.  … Continued

Hyris Technology Supports the Fight Against One of the World’s Deadliest Diseases, Malaria

By API User

Hyris’ molecular diagnostic technology has been adapted to enable real-time surveillance of mosquito vector insecticide resistance, which will aid in malaria control campaigns. LONDON, UK / ACCESSWIRE / February 20, 2024 / Hyris, working with an international team of researchers, has developed a prototype field-deployable surveillance system to detect insecticide-resistant malaria vector mosquitoes in the … Continued

When art collides with science and technology, magic happens: ANAT Synapse 2024 residents announced

By API User

When art collides with science and technology, magic happens   ANAT Synapse 2024 residents announced $20,000 Fellowship unveiled celebrating 20 years of art + science synergy For the past 36 years, the Australian Network for Art & Technology (ANAT) has cultivated opportunities for artists to create experimental work in and with science and technology, playing … Continued

Blood test to detect dementia: expert available for comment

By API User

Professor Matthew Kiernan AM CEO at Neuroscience Research Australia is available to provide expert comment on the development of an early blood test to predict dementia, as reported by the Guardian today based on research published in nature aging.  Professor Kiernan AM is an expert in neurodegenerative diseases, particularly motor neuron disease (MND) and frontotemporal dementia … Continued

New study reveals kill order for melanoma cells by cannabis extract

By API User

A cannabis extract has shown positive results in slowing down melanoma cell growth and increasing cell death rates, a new in-vitro study finds. Researchers from Charles Darwin University (CDU) and RMIT investigated programmed cell death caused by a specific cannabis extract (cannabinoid PHEC-66) from the cannabis sativa plant. The study that was part of a PhD project … Continued